Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 3, 2016
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - December 3, 2016

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/3/16 - "Reticulocyte Growth Factor and Preparing Method and Application Thereof" in Patent Application Approval Process (USPTO 20160326226)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors JIN, YIFENG; WU, QI; ZHANG, TAIPING; MA, XIAOYAN; XUAN, JI, filed on January 27, 2014, was made available online on November 17, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent ap
12/3/16 - "Vegf Antagonist Compositions and Uses Thereof" in Patent Application Approval Process (USPTO 20160326501)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors Stefano, James; Pan, Clark; Qui, Huawei; O'Callaghan, Michael; Matthews, Gloria, filed on July 25, 2016, was made available online on November 17, 2016, according to news reporting originating from Washington, D.C., by NewsRx corresponden
12/3/16 - CSL Behring Presents Positive Results from the CSL112 AEGIS-I Phase 2b Trial
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week CSL Behring announced positive results from AEGIS-I, a Phase 2 b safety and proof of mechanism clinical study of CSL112, a novel apolipoprotein A-I infusion therapy. Results from AEGIS-I were presented today at the American Heart Association Scientific Sessions in New Orleans
12/3/16 - Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Cumberland Pharmaceuticals, a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S. rights to Nordic Group B.V.' s innovative injectable methotrexate product line. Under the terms of the Agreement, Cumberland will be responsible for
12/3/16 - Inj.anti-rabies Vaccine Containing Purified Chick Embryo Or Verocell Culture Or Human Deploid Vaccine 2.5 I.u. Per Vial. [TendersInfo (India)]
Tenders are invited for Inj.Anti-Rabies Vaccine Containing Purified Chick Embryo Or Verocell Culture Or Human Deploid Vaccine 2.5 I.U. Bidding System: Single Bid System. As Per Drug Procurement Policy-2014, It Is Mentioned That Except Imported Drugs, If The Registered Firms Is/Are Marketing Drugs Manufactured By Other Manufacturing Units, Then...
12/3/16 - Nutra Pharma Announces Infomercial Campaign for Pet Pain-Away
By a News Reporter-Staff News Editor at Marketing Weekly News Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced that DEG..
12/3/16 - Procurement of Veterinary Drugs and Chemicals under the Office of Deputy Director Livestock Medicine Store [TenderNews.com - Tenders (India)]
Procurement of Veterinary Drugs and Chemicals under the Office of Deputy Director Livestock Medicine Store more info: Location: Bangladesh BidDate: 12/19/2016 Tender Country: Bangladesh Tender Type: Tenders Tendering Authority: Bangladesh Power Development Board Tendering Authority Address: Contact Person: Dr.M.M Daulotana Address:: DD Livestock...
12/3/16 - Procurement of Veterinary Drugs( Disinfectants) and Chemicals office at the Deputy Director Livestock Medicine Store [TenderNews.com - Tenders (India)]
Procurement of Veterinary Drugs and Chemicals office at the Deputy Director Livestock Medicine Store more info: Location: Bangladesh BidDate: 12/19/2016 Tender Country: Bangladesh Tender Type: Tenders Tendering Authority: Bangladesh Power Development Board Tendering Authority Address: Contact Person: Dr.M.M Daulotana Address:: DD Livestock Medicine
12/3/16 - Procurement of Veterinary Drugs(Antibiotics and Sulpha) at Office of the Deputy Director Livestock Medicine Store [TenderNews.com - Tenders (India)]
Procurement of Veterinary Drugs at Office of the Deputy Director Livestock Medicine Store more info: Location: Bangladesh BidDate: 12/22/2016 Tender Country: Bangladesh Tender Type: Tenders Tendering Authority: Bangladesh Power Development Board Tendering Authority Address: Contact Person: Dr.M.M Daulotana Address:: DD Livestock Medicine Store Offi
12/3/16 - Procurement of Veterinary Drugs(Antibiotics and Sulpha) offce at the Deputy Director Livestock Medicine Store [TenderNews.com - Tenders (India)]
Procurement of Veterinary Drugs offce at the Deputy Director Livestock Medicine Store more info: Location: Bangladesh BidDate: 12/22/2016 Tender Country: Bangladesh Tender Type: Tenders Tendering Authority: Bangladesh Power Development Board Tendering Authority Address: Contact Person: Dr.M.M Daulotana Address:: DD Livestock Medicine Store Office 4
12/3/16 - Procurement of Veterinary Drugs(Disinfectants and Chemicals) offce at the Deputy Director Livestock Medicine Store [TenderNews.com - Tenders (India)]
Procurement of Veterinary Drugs offce at the Deputy Director Livestock Medicine Store more info: Location: Bangladesh BidDate: 12/20/2016 Tender Country: Bangladesh Tender Type: Tenders Tendering Authority: Bangladesh Power Development Board Tendering Authority Address: Contact Person: Dr.M.M Daulotana Address:: DD Livestock Medicine Store Office 4
12/3/16 - Scientists develop new device to treat cancer and other ailments [Daily News Egypt]
In a recent study, scientists from The University of Texas invented a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments. Led by Lyle Hood, the study was published in the Journal of Biomedical Nanotechnology. "The problem with most drug-delivery systems is that you have a s
12/3/16 - Simpler website navigation for regulatory information on human medicines
LONDON, 01 December 2016/ PRNewswire Policy/ New navigation to help users find information more easily. The European Medicines Agency has simplified the navigation structure of the regulatory information on human medicines on its website, to help users from pharmaceutical companies find the information they need more quickly and easily.
12/3/16 - Treatment of rare skin disorder by Amryt gets EUR 20m backing from EIB's first ever pharma loan in Ireland
LUXEMBOURG, 02 December 2016/ PRNewswire Policy/ Sufferers of rare skin disorders will benefit from new treatment being developed by Amryt Pharma to be supported by the European Investment Bank' s first direct backing for pharmaceutical investment by an Irish company. The agreement for the new EUR 20 million loan was formally agreed at the Europe
12/3/16 - Workshop: measuring the impact of pharmacovigilance activities
LONDON, 28 November 2016/ PRNewswire Policy/ The event will be web-streamed on 5-6 December. The European Medicines Agency is organising a workshop to discuss methods to measure the impact of pharmacovigilance activities on patient safety. The event will be web-streamed from the EMA premises in London, from 13:00 UK time on 5 December to 17:00 UK
12/2/16 - "Capsule Pharmaceutical Dosage Form Comprising a Suspension Formulation of an Indolinone Derivative" in Patent Application Approval Process (USPTO...
"Capsule Pharmaceutical Dosage Form Comprising a Suspension Formulation of an Indolinone Derivative" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors MESSERSCHMID, Roman; BINDER, Rudolf; BOCK, Thomas; BROX, Werner, filed on July 7, 2016, was made available online on No
12/2/16 - "Hypericin Albumin Nanoparticle-Escherichia Coli Serum Antibody Complex and Preparation Method and Application Thereof" in Patent Application...
"Hypericin Albumin Nanoparticle-Escherichia Coli Serum Antibody Complex and Preparation Method and Application Thereof" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors LIANG, JIANPING; GUO, WENZHU; HAO, BAOCHENG; TAO, LEI; LIU, YU; WANG, XUEHONG; SHANG, RUOFENG; GUO,
12/2/16 - "Optimized Pharmaceutical Formulation for the Treatment of Inflammatory Conditions of the Esophagus" in Patent Application Approval Process (USPTO...
"Optimized Pharmaceutical Formulation for the Treatment of Inflammatory Conditions of the Esophagus" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors GREINWALD, Roland; MUELLER, Ralph; PROELS, Markus; WILHELM, Rudolf, filed on December 18, 2014, was made available onli
12/2/16 - AbbVie's HUMIRA Adalimumab Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease
By a News Reporter-Staff News Editor at Drug Week AbbVie, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for HUMIRA for the treatment of active moderate to severe hidradenitis suppurativa in adolescents from 12 years of age wi
12/2/16 - ABPI gives evidence to Exiting the EU Commons Select Committee on Brexit priorities
Release date- 01122016- Dr Virginia Acha, ABPI's Executive Director of Research, Medical and Innovation has told MPs on the Exiting the European Union Committee that for the UK pharmaceutical industry a primary objective for Government in Brexit negotiations should be to secure alignment and cooperation with EU medicines regulation.
12/2/16 - Advanced Medical Isotope Wins Default Judgment of $527,875.74
KENNEWICK, WA/ ACCESSWIRE/ December 2, 2016/ Advanced Medical Isotope Corporation, a late stage radiation oncology focused medical device company, announced today that it has been awarded in the Superior Court of the State of Washington in and for Benton County, a total judgment of...
12/2/16 - Agenda Released for Controlled Release Delivery: FDA, Janssen, GSK and Boehringer Ingelheim to Present Next April
SMi is thrilled to announce the release of the highly anticipated brochure for 14th annual Controlled Release Delivery taking place on 3rd to 4th of April in London.
12/2/16 - Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc., a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor, today announced the company granted a newly hired executive an option to purchase 130,000 shares of the company s common stock with a per share exercise price of $8.61,
12/2/16 - Akebia Therapeutics (AKBA) Buy Rating Reiterated with Higher Stock Price Target of $18
Akebia Therapeutics, Inc., a biopharma company that focuses on the development of innovative treatments for chronic kidney disease-related anemia, is maintaining its Buy rating, with a recommended stock price target of $18 compared to the current $8.90, according to an Aegis Capital Corp. report released on November 15. Both trials have been
12/2/16 - Allergan Announces Settlement of a DELZICOL (mesalamine) Patent Litigation
Allergan plc, a leading global pharmaceutical company, and its subsidiaries today announced that they, along with Qualicaps Co., Ltd., have reached a settlement regarding their litigation with Zydus Pharmaceuticals Inc., and Cadila Healthcare Limited relating to United States Patent No. 6,649,180 and Allergan's DELZICOL product. Allergan plc,.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415